Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine
Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the ...
May 24, 2023
0
55